Active	Status	Sponsor type	Region	Phase	Filter
13 Active 9 Inactive 22 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

10 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Merkely, Béla
NCT06292013: A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)	Recruiting	3	12500	Europe, Canada, Japan, US, RoW	Lepodisiran Sodium, LY3819469, Placebo	Eli Lilly and Company	Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a)	03/29	03/29
NCT06383390: The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)	Recruiting	3	10000	Europe, Canada, US, RoW	Retatrutide, LY3437943, Placebo	Eli Lilly and Company	Atherosclerotic Cardiovascular Disease (ASCVD), Chronic Kidney Disease (CKD)	02/29	02/29
KRAKEN, NCT05563246: A Study of LY3473329 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events	Completed	2	233	Europe, Japan, US, RoW	LY3473329, Placebo	Eli Lilly and Company	Lipoprotein Disorder	03/24	03/24
NCT05592275: A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)	Active, not recruiting	2	456	Europe, Canada, Japan, US, RoW	LY3540378, Placebo	Eli Lilly and Company	Heart Failure, Heart Failure With Preserved Ejection Fraction	01/25	01/25
NCT03616678: VenTouch OUS Feasibility Study	Recruiting	N/A	15	Europe, Canada, RoW	VenTouch System	Mardil Medical	Functional Mitral Regurgitation	05/21	12/23
NCT02270840: Budapest Upgrade CRT Study (Version 009-4.1)	Completed	N/A	360	Europe, RoW	CRT-D	Semmelweis University Heart and Vascular Center, University of Rochester, Sheba Medical Center, Pharmahungary Group	Cardiomyopathy	08/22	08/22
NCT05462405: Evaluation of Sympathetic Activity Effects by the BackBeat Medical Cardiac Neuromodulation Therapy (CNT).	Recruiting	N/A	15	Europe	Experimental group	BackBeat Medical Inc	Hypertension	09/23	12/23
NCT05719454: Novel Setup Algorithm for Cardiac Neuromodulation Therapy	Recruiting	N/A	30	Europe, RoW	CNT testing	BackBeat Medical Inc	Hypertension, Bradycardia	07/24	10/24
BIO|STREAM HF, NCT03366545: Observation of Clinical Routine Care for Heart Failure Patients Implanted With BIOTRONIK CRT Devices	Recruiting	N/A	3000	Europe, Japan, RoW	Cardiac Resynchronization Therapy (CRT)	Biotronik SE & Co. KG	Heart Failure	03/26	03/26
NCT06048731: Enlighten Study: The EV-ICD Post Approval Registry	Recruiting	N/A	1000	Europe, Canada, US, RoW	Defibrillation using EV-ICD	Medtronic	Ventricular Arrhythmia, Tachycardia	05/30	10/37